Catalyst Wire Dossier Catalyst Wire Dossier

elamipretide topical ophthalmic solution

elamipretide · Stealth BioTherapeutics Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for elamipretide topical ophthalmic solution, covering 2021-09-17 to 2021-10-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy [Phase 2]

See pricing